Baker Biotech Capital (GP), LLC Insider Trading $INCY INCYTE CORP
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Biotech Capital (GP), LLC in INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 2,933,021 shares
Current Value: $346,624,422
Latest Transaction: Sep 23 2010
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in INCYTE CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 23 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.86 | 70,150 | 1,042,485 | 2,933,021 | 3 M to 2.9 M (-2.34 %) |
Sep 23 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.71 | 88,670 | 1,304,495 | 3,003,171 | 3.1 M to 3 M (-2.87 %) |
Sep 23 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.94 | 238,230 | 3,559,871 | 3,091,841 | 3.3 M to 3.1 M (-7.15 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.00 | 22,751 | 318,468 | 3,330,071 | 3.4 M to 3.3 M (-0.68 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.00 | 11,711 | 163,953 | 3,352,822 | 3.4 M to 3.4 M (-0.35 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.08 | 74,201 | 1,044,847 | 3,364,533 | 3.4 M to 3.4 M (-2.16 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Sell | S | 14.09 | 48,266 | 679,938 | 3,438,734 | 3.5 M to 3.4 M (-1.38 %) |
Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 485,000 | 5,440,973 | 3,597,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 388,000 | 4,352,778 | 15,055,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 182,000 | 2,041,767 | 14,667,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 546,000 | 6,125,301 | 14,485,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.16 | 1,248 | 2,693 | 3,487,000 | 3.5 M to 3.5 M (+0.04 %) |
Mar 05 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.14 | 2,199 | 4,709 | 3,485,752 | 3.5 M to 3.5 M (+0.06 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 1,818,000 | 20,395,233 | 13,939,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 454,000 | 5,093,199 | 12,121,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 691,000 | 7,751,984 | 11,667,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 1,761,000 | 19,755,779 | 10,976,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.17 | 3,682 | 7,993 | 3,483,553 | 3.5 M to 3.5 M (+0.11 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 2.14 | 4,019 | 8,587 | 3,479,871 | 3.5 M to 3.5 M (+0.12 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 1,422,000 | 15,954,840 | 9,215,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 2,383,000 | 26,737,260 | 2,383,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.60 | 75,808 | 272,560 | 3,475,840 | 3.4 M to 3.5 M (+2.23 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.62 | 13,433 | 48,594 | 3,400,032 | 3.4 M to 3.4 M (+0.40 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.56 | 64,559 | 230,043 | 3,386,599 | 3.3 M to 3.4 M (+1.94 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.60 | 3,904 | 14,041 | 3,322,040 | 3.3 M to 3.3 M (+0.12 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.33 | 41,510 | 138,303 | 3,318,136 | 3.3 M to 3.3 M (+1.27 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.33 | 25,153 | 83,865 | 3,276,626 | 3.3 M to 3.3 M (+0.77 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 3.15 | 2,903 | 9,144 | 3,251,473 | 3.2 M to 3.3 M (+0.09 %) |
Aug 05 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.00 | 201,648 | 1,814,832 | 3,248,570 | 3 M to 3.2 M (+6.62 %) |
Jan 24 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.62 | 65 | 690 | 3,046,922 | 3 M to 3 M (0.00 %) |
Jan 16 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.99 | 13,675 | 150,254 | 3,046,857 | 3 M to 3 M (+0.45 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.94 | 12,120 | 132,548 | 3,033,182 | 3 M to 3 M (+0.40 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 11.01 | 490 | 5,392 | 3,021,062 | 3 M to 3 M (+0.02 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.94 | 35,783 | 391,566 | 3,020,572 | 3 M to 3 M (+1.20 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.00 | 9,541 | 95,368 | 2,984,789 | 3 M to 3 M (+0.32 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.89 | 181,168 | 1,973,644 | 2,975,248 | 2.8 M to 3 M (+6.48 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.48 | 83,853 | 795,019 | 2,794,080 | 2.7 M to 2.8 M (+3.09 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.47 | 118,009 | 1,117,144 | 2,710,227 | 2.6 M to 2.7 M (+4.55 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.61 | 35,234 | 373,755 | 2,592,218 | 2.6 M to 2.6 M (+1.38 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.58 | 21,261 | 225,020 | 2,556,984 | 2.5 M to 2.6 M (+0.84 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.60 | 37,354 | 395,777 | 2,535,723 | 2.5 M to 2.5 M (+1.50 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 10.38 | 67,353 | 699,454 | 2,498,369 | 2.4 M to 2.5 M (+2.77 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.85 | 26,336 | 259,433 | 2,431,016 | 2.4 M to 2.4 M (+1.10 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.87 | 34,670 | 342,262 | 2,404,680 | 2.4 M to 2.4 M (+1.46 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 9.54 | 42,843 | 408,906 | 2,370,010 | 2.3 M to 2.4 M (+1.84 %) |
Dec 06 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.98 | 19,593 | 175,980 | 2,327,167 | 2.3 M to 2.3 M (+0.85 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.96 | 4,241 | 38,007 | 2,307,574 | 2.3 M to 2.3 M (+0.18 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.59 | 9,764 | 83,882 | 2,303,333 | 2.3 M to 2.3 M (+0.43 %) |
Dec 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.58 | 3,125 | 26,809 | 2,293,569 | 2.3 M to 2.3 M (+0.14 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.40 | 22,741 | 190,940 | 2,290,444 | 2.3 M to 2.3 M (+1.00 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.00 | 35,237 | 281,797 | 2,267,703 | 2.2 M to 2.3 M (+1.58 %) |
Nov 28 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 7.94 | 15,282 | 121,322 | 2,232,466 | 2.2 M to 2.2 M (+0.69 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.12 | 9,961 | 80,883 | 2,217,184 | 2.2 M to 2.2 M (+0.45 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.10 | 13,945 | 112,974 | 2,207,223 | 2.2 M to 2.2 M (+0.64 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.22 | 46,836 | 385,151 | 2,193,278 | 2.1 M to 2.2 M (+2.18 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.30 | 33,157 | 275,286 | 2,146,442 | 2.1 M to 2.1 M (+1.57 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.63 | 60 | 518 | 2,113,285 | 2.1 M to 2.1 M (0.00 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.62 | 42,783 | 368,914 | 2,113,225 | 2.1 M to 2.1 M (+2.07 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.53 | 49,390 | 421,183 | 2,070,442 | 2 M to 2.1 M (+2.44 %) |
Nov 16 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.54 | 709 | 6,055 | 2,021,052 | 2 M to 2 M (+0.04 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.25 | 34,518 | 284,791 | 2,020,343 | 2 M to 2 M (+1.74 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.26 | 7,843 | 64,771 | 1,985,825 | 2 M to 2 M (+0.40 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.22 | 5,727 | 47,095 | 1,977,982 | 2 M to 2 M (+0.29 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.30 | 9,239 | 76,674 | 1,972,255 | 2 M to 2 M (+0.47 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.00 | 4,413 | 35,283 | 1,963,016 | 2 M to 2 M (+0.23 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.23 | 8,456 | 69,625 | 1,958,603 | 2 M to 2 M (+0.43 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.20 | 68,249 | 559,676 | 1,950,147 | 1.9 M to 2 M (+3.63 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 8.30 | 55,704 | 462,349 | 1,881,898 | 1.8 M to 1.9 M (+3.05 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 7.70 | 78,599 | 605,425 | 1,826,194 | 1.7 M to 1.8 M (+4.50 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 7.90 | 1,434 | 11,323 | 1,747,595 | 1.7 M to 1.7 M (+0.08 %) |
Aug 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.83 | 64,003 | 308,859 | 1,746,161 | 1.7 M to 1.7 M (+3.80 %) |
Aug 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.99 | 17,446 | 87,106 | 1,682,158 | 1.7 M to 1.7 M (+1.05 %) |
Aug 03 2007 | INCY | INCYTE CORP | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 4.95 | 89,883 | 444,588 | 1,664,712 | 1.6 M to 1.7 M (+5.71 %) |
Page: 1